Eisai Inc. is a Japanese pharmaceutical company that is headquartered in Tokyo. The company has a long history in the industry and manufactures various drugs that are then distributed in various countries across the world. Belviq is the brand name of a weight-loss drug lorcaserin manufactured by Eisai Inc, which was recalled by the company voluntarily when the FDA identified various side effects associated with it mainly increased risk of developing cancer.
There have been concerns regarding Belviq even before it was approved by the FDA. A study in 2007 by Arena Pharmaceuticals Inc. found that lorcaserin led to the development of rare and aggressive tumours among rats, however, Arena and Eisai allegedly ignored the results and resubmitted the application of approval to the FDA in 2012.
Although the company did receive an approval in 2013 for weight-loss patients but with a recommendation that the company should continue conducting more trials to assess if it is developing any cardiovascular problems in patients or not. As soon as the company received the approval, they started marketing it and healthcare professionals have started prescribing it, while the study recommended by the FDA was still going on. The FDA later discovered that most of the patients who volunteered for clinical trials are being diagnosed with cancer.
Had the FDA received the results before approval or access to Arean’s study in 2007, the organization would never have approved it – this was a position taken by Barbara Zottola who filed a lawsuit against Eisai Inc. By the time Belviq cancer lawsuit was filed, the damage had already been done and the only thing affected individuals can get now is justice.
If you have been affected by Belviq, then it is time to come forward and seek compensation for your pain and suffering.
Receive the Compensation You Deserve!
FREE No Obligation Consultation Pay Nothing!
Your Claim Review is Confidential!
LAWSUITS BEING FILED
Yes. The FDA has asked the company to recall Belviq from the market, after the revelation that it is causing cancer among the patients.
Belviq does not only cause cancer but also has other side effects. Unfortunately, the reputation of weight-loss drugs is not a pristine one and Belviq is no different. But keeping the patients and the regulator in dark led to increasing in complaints related to Belviq. The weight-loss drug may cause any of the following types of cancers:
- Belviq Pancreatic Cancer
- Belviq Colon Cancer
- Belviq Lung Cancer
The other side effects that you may experience after taking Belviq are:
- Dry Mouth
Yes. The studies have revealed that Belviq is also linked to breast cancer, brain cancers, and other types of cancers. It may vary from patient to patient and you should consult your healthcare professional if you suspect that you are experiencing any side effects of Belviq.
If you are diagnosed with cancer and have taken Belviq in the past, then you should explore your legal options against the drug manufacturer. But before you seek legal counsel, do review the following eligibility criteria:
- Diagnosed with cancer after consuming Belviq or any other lorcaserin brand.
- Your age is 18 or above